Pharmaceutical services strengthen the brazilian Unified Health System: experience of the practice of technical and clinical activities that result in safety
Keywords:Unified Health System; Pharmaceutical Services; Evidence-Based Pharmacy Practice; Patient-Centered Care; Patient safety.
Objective: To report the experience of the practice of pharmaceutical services in a hospital of the Unified Health System (Sistema Único de Saúde - SUS) and describe the development outcomes of the technical and clinical activities performed. Method: A descriptive study, with an experience report, was carried out at the Hospital Estadual de Ribeirão Preto, in the year 2021. The institution is a medium-sized hospital complex that provides health care (hospital and outpatient) to Ribeirão Preto, State of São Paulo, and 25 other neighboring municipalities. Pharmaceutical services were performed by nine pharmacists and a pharmacy assistant, as well as being characterized by operational and clinical practices. The report of the sector's daily life was then detailed as a successful experience of the SUS. Results: Pharmaceutical services were structured through an institutional policy of safety in the use of medicines, which standardized the selection and distribution of medicines, taking into account good practices and the adoption of methods to avoid errors and adverse events. In addition, clinical services related to pharmaceutical care included medication reconciliation, pharmacotherapy review and pharmacotherapeutic follow-up, which were guided by evidence-based health practice. A 91.3% rate of acceptance by the health team to the actions of pharmaceutical services provided validation of the method used and the more than 750 interventions (technical and clinical) carried out supported the success of the experience. Conclusion: This study exposed a real-life experience related to the development of pharmaceutical services in a SUS hospital institution and it can support the structuring of these practices in other similar units.
American Geriatrics Society. (2019). American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. Journal of the American Geriatrics Society, 67(4), 674-694. doi: 10.1111/jgs.15767
Ayalew, M. B., Tegegn, H. G. & Abdela, O. A. (2019). Drug related hospital admissions; a systematic review of the recent literatures. Bulletin of Emergency and Trauma, 7(4), 339-46. doi: 10.29252/beat-070401
Bernardes, J. M., Ruiz-Frutos, C., Moro, A. R. P. & Dias, A. (2021). A low-cost and efficient participatory ergonomic intervention to reduce the burden of work-related musculoskeletal disorders in an industrially developing country: an experience report. International Journal of Occupational Safety and Ergonomics, 27(2), 452-9. doi: 10.1080/10803548.2019.1577045
Couto, R. C., Pedrosa, T. M. G. & Rosa, M. B. (2016). Erros acontecem: A força da transparência no enfrentamento dos eventos adversos assistenciais em pacientes hospitalizados. Belo Horizonte, Brasil: UFMG/IESS.
da Silva, K. F., Torres, A. S. F. & Soler, O. (2022). Evidências sobre tipos de intervenções para a institucionalização da assistência farmacêutica: revisão integrativa. Research, Society and Development, 11(3), e55811326979. doi: 10.33448/rsd-v11i3.26979
de Oliveira, A. M., Varallo, F. R., Rodrigues, J. P. V., Aguilar, G. J., Lima, N. K. C. & Pereira, L. R. L. (2022). Contribution of Pharmaceutical Care to Person-centered Health Care and the Safety of Pharmacotherapy for Hospitalized Older Individuals in Brazil: An Investigative Single-arm Intervention Trial. Current Drug Safety, 17. doi: 10.2174/157488631766622061414043
Fu, A. Z., Jiang, J. Z., Reeves, J. H., Fincham, J. E., Liu, G. G. & Perri III, M. (2007). Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Medical Care, 45(5), 472-6. doi: 10.1097/01.mlr.0000254571.05722.34
Graabæk, T. & Kjeldsen, L. J. (2013). Medication Reviews by Clinical Pharmacists at Hospitals Lead to Improved Patient Outcomes: A Systematic Review. Basic & Clinical Pharmacology & Toxicology, 112(6), 359-73. doi: 10.1111/bcpt.12062
Gurwitz, J. H., Field, T. S., Harrold, L. R., Rothschild, J., Debellis, K., Seger, A. C., Cadoret, C., Fish, L. S., Garber, L., Kelleher, M. & Bates, D. W. (2003). Incidence and preventability of adverse drug events among older persons in the ambulatory setting. Jama, 289(9), 1107-16. doi: 10.1001/jama.289.9.1107
Gurwitz, J. H., Field, T. S., Judge, J., Rochon, P., Harrold, L. R., Cadoret, C., Lee, M., White, K., LaPrino, J., Erramuspe-Mainard, J., DeFlorio, M., Gavendo, L., Auger, J. & Bates, D. W. (2005). The incidence of adverse drug events in two large academic long-term care facilities. The American Journal of Medicine, 118(3), 251-8. doi: 10.1016/j.amjmed.2004.09.018
Institute for Safe Medication Practices. (2018). High-Alert Medication Survey Results Lead to Several Changes for 2018. Pennsylvania, USA: Institute for Safe Medication Practices. Retrieved from https://www.ismp.org/resources/high-alert-medication-survey-results-lead-several-changes-2018
Law, M. G., Maposa, P., Steeb, D. R. & Duncan, G. (2017). Addressing the global need for public health clinical pharmacists through student pharmacist education: a focus on developing nations. International Journal of Clinical Pharmacy, 39(6), 1141–4. doi: 10.1007/s11096-017-0537-0
Lee, V. W., Yi, P. T., Kong, K. W., Chan, P. K. & Kwok, F. L. (2013). Impact of pharmacy outreach services on blood pressure management in the elderly community of Hong Kong. Geriatrics & Gerontology International, 13(1), 175–81. doi: 10.1111/j.1447-0594.2012.00881.x
León, M. P., Ramos, H. A., Munguía, S. G., Penichet, S. M. M. & Gómez, R. M. (2014). Evaluación de la calidad de las intervenciones farmacéuticas en urgencias basada en la evidencia científica. Farmacia Hospitalaria, 38(2), 123-9. doi: 10.7399/FH.2014.38.2.981
Magid, D. J., Olson, K. L., Billups, S. J., Wagner, N. M., Lyons, E. E. & Kroner, B. A. (2013). A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes, 6(2), 157–63. doi: 10.1161/CIRCOUTCOMES.112.968172
Makary, M. A. & Daniel, M. (2016). Medical error—the third leading cause of death in the US. British Medical Journal, 353. doi: 10.1136/bmj.i2139
Marques, L. A. M. (2013). Geriatria. Atenção farmacêutica em distúrbios maiores. 2 ed. São Paulo, Brasil: Medfarma.
Ministério da Saúde. (2015). Cuidado Farmacêutico na Atenção Básica. Brasília, Brasil: Ministério da Saúde.
Ministério da Saúde. (2020). RDC Nº 406 - Dispõe sobre as Boas Práticas de Farmacovigilância para Detentores de Registro de Medicamento de uso humano, e dá outras providências. Brasília, Brasil: Ministério da Saúde.
Morais, D. A., Moraes, C. M. G., Souza, K. M. & Alves, R. L. (2021). Mobile pre-hospital care reorganization during the COVID-19 pandemic: experience report. Revista Brasileira de Enfermagem, 75(Suppl 1), e20200826. doi: 10.1590/0034-7167-2020-0826
Pande, S., Hiller, J. E., Nkansah, N. & Bero, L. (2013). The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database of Systematic Reviews, (2). doi: 10.1002/14651858.CD010398
Rodrigues, J. P. V., Marques, F. A., Gonçalves, A. M. R. F., Campos, M. S. A., dos Reis, T. M., Morelo, M. R. S., Fontoura, A., Girolineto, B. M. P., Souza, H. P. M. C., Cazarim, M. S., Maduro, L. C. S. & Pereira, L. R. L. (2019). Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital. PloS one, 14(1), e0210779. doi: 10.1371/journal.pone.0210779
Suggett, E. & Marriott, J. (2016). Risk Factors Associated with the Requirement for Pharmaceutical Intervention in the Hospital Setting: A Systematic Review of the Literature. Drugs - Real World Outcomes, 3(3), 241-63. doi: 10.1007/s40801-016-0083-4
World Health Organization. (1997). The role of the pharmacist in the health care system: preparing the future pharmacist. Geneva, Switzerland: World Health Organization.
World Health Organization. (2004). World alliance for patient safety: forward programme. Geneva, Switzerland: World Health Organization.
World Health Organization. (2006). Developing pharmacy practice: a focus on patient care. Geneva, Switzerland: World Health Organization.
World Health Organization. (2007). Report on the results of the web-based modified delphi survey of the international classification for patient safety overview. Geneva, Switzerland: World Health Organization.
World Health Organization. (2017). Medication without harm: global patient safety challenge on medication safety. Geneva, Switzerland: World Health Organization.
How to Cite
Copyright (c) 2022 Alan Maicon de Oliveira; Marina Del Vecchio Filipin; Débora Alves Reis; Lázara Mariane Moreira Monteiro; Camila Cubayachi; Isabella Ribeiro Ramos Madruga; Mariana Honorato Giardini
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.